학술논문
88TiP A phase Ib study of HMBD-001, a monoclonal antibody targeting HER3, with or without chemotherapy in patients with genetic aberrations in HER3 signaling.
Document Type
Article
Author
Source
Subject
*MONOCLONAL antibodies
*CANCER chemotherapy
*
Language
ISSN
0923-7534